MYCN and neuroblastoma: Two MYCN-amplifying NB cell lines, BE(2)-C and IMR-32, and two non-MYCN-amplifying NB cell lines, SK-N-SH and SH-SY5Y, were treated with JQ1 alone and Olaparib alone to identify the IC50 doses of each drug.